Filed: 5/15/2026ACC: 0001172661-26-002272
📋 What this filing means
GREAT POINT PARTNERS LLC filed this quarterly 13F‑HR report disclosing 42 equity positions with a total reported market value of $435.12M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
42
Positions
$435.12M
Total AUM (reported)
48.47M
Total Shares
Allocation by class
COM$224.18M51.5%
COM NEW$109.59M25.2%
CLASS A ORD SHS$25.08M5.8%
SHS NEW$21.74M5.0%
COM SHS$19.59M4.5%
CL A$18.47M4.2%
CLASS A ORD$9.32M2.1%
Portfolio Concentration
Top 3$87.78M20.2%
4–10$140.61M32.3%
11–25$144.56M33.2%
Rest$62.16M14.3%
Top 3 weight
20.2%
Top 10 weight
52.5%
Voting Authority Distribution
Total shares with voting rights: 48.47M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
48.47M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other42
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings42
Rows:
APOGEE THERAPEUTICS INC
DFNDShares374K
TypeSH
Market value$31.48M
7.23%
Sole
0.00
Shared
374K
None
0.00
VOR BIOPHARMA INC
DFNDShares1.75M
TypeSH
Market value$31.22M
7.18%
Sole
0.00
Shared
1.75M
None
0.00
ZURA BIO LTD
DFNDShares4.22M
TypeSH
Market value$25.08M
5.77%
Sole
0.00
Shared
4.22M
None
0.00
AMYLYX PHARMACEUTICALS INC
DFNDShares1.75M
TypeSH
Market value$24.32M
5.59%
Sole
0.00
Shared
1.75M
None
0.00
IMMUNITYBIO INC
DFNDShares3M
TypeSH
Market value$23.02M
5.29%
Sole
0.00
Shared
3M
None
0.00
NEKTAR THERAPEUTICS
DFNDShares316.45K
TypeSH
Market value$22.77M
5.23%
Sole
0.00
Shared
316.45K
None
0.00
SOL-GEL TECHNOLOGIES LTD
DFNDShares274.36K
TypeSH
Market value$21.74M
5.00%
Sole
0.00
Shared
274.36K
None
0.00
ALUMIS INC
DFNDShares856.06K
TypeSH
Market value$18.86M
4.33%
Sole
0.00
Shared
856.06K
None
0.00
BRIGHT MINDS BIOSCIENCES INC
DFNDShares220K
TypeSH
Market value$16.05M
3.69%
Sole
0.00
Shared
220K
None
0.00
ANNEXON INC
DFNDShares2.50M
TypeSH
Market value$13.85M
3.18%
Sole
0.00
Shared
2.50M
None
0.00
KALVISTA PHARMACEUTICALS INC
DFNDShares675K
TypeSH
Market value$13.59M
3.12%
Sole
0.00
Shared
675K
None
0.00
IMMUNOVANT INC
DFNDShares545.63K
TypeSH
Market value$13.55M
3.11%
Sole
0.00
Shared
545.63K
None
0.00
JADE BIOSCIENCES INC
DFNDShares964.46K
TypeSH
Market value$13.55M
3.11%
Sole
0.00
Shared
964.46K
None
0.00
CONTINEUM THERAPEUTICS INC
DFNDShares800.20K
TypeSH
Market value$10.45M
2.40%
Sole
0.00
Shared
800.20K
None
0.00
ZENAS BIOPHARMA INC
DFNDShares524.07K
TypeSH
Market value$10.25M
2.35%
Sole
0.00
Shared
524.07K
None
0.00
NEUROGENE INC
DFNDShares500K
TypeSH
Market value$10.08M
2.32%
Sole
0.00
Shared
500K
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
DFNDShares500K
TypeSH
Market value$9.32M
2.14%
Sole
0.00
Shared
500K
None
0.00
CLIMB BIO INC
DFNDShares1.33M
TypeSH
Market value$9.14M
2.10%
Sole
0.00
Shared
1.33M
None
0.00
ORUKA THERAPEUTICS INC
DFNDShares183.33K
TypeSH
Market value$8.99M
2.07%
Sole
0.00
Shared
183.33K
None
0.00
EUPRAXIA PHARMACEUTICALS INC
DFNDShares1.20M
TypeSH
Market value$8.69M
2.00%
Sole
0.00
Shared
1.20M
None
0.00
VERA THERAPEUTICS INC
DFNDShares199.35K
TypeSH
Market value$8.02M
1.84%
Sole
0.00
Shared
199.35K
None
0.00
EVOMMUNE INC
DFNDShares325K
TypeSH
Market value$7.47M
1.72%
Sole
0.00
Shared
325K
None
0.00
LB PHARMACEUTICALS INC
DFNDShares300K
TypeSH
Market value$7.40M
1.70%
Sole
0.00
Shared
300K
None
0.00
COMPASS THERAPEUTICS INC
DFNDShares1.35M
TypeSH
Market value$7.14M
1.64%
Sole
0.00
Shared
1.35M
None
0.00
SCYNEXIS INC
DFNDShares7.55M
TypeSH
Market value$6.93M
1.59%
Sole
0.00
Shared
7.55M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APOGEE THERAPEUTICS INCDFND | COM | 374K | SH | $31.48M 7.23% | 0.00 | 374K | 0.00 |
VOR BIOPHARMA INCDFND | COM NEW | 1.75M | SH | $31.22M 7.18% | 0.00 | 1.75M | 0.00 |
ZURA BIO LTDDFND | CLASS A ORD SHS | 4.22M | SH | $25.08M 5.77% | 0.00 | 4.22M | 0.00 |
AMYLYX PHARMACEUTICALS INCDFND | COM | 1.75M | SH | $24.32M 5.59% | 0.00 | 1.75M | 0.00 |
IMMUNITYBIO INCDFND | COM | 3M | SH | $23.02M 5.29% | 0.00 | 3M | 0.00 |
NEKTAR THERAPEUTICSDFND | COM NEW | 316.45K | SH | $22.77M 5.23% | 0.00 | 316.45K | 0.00 |
SOL-GEL TECHNOLOGIES LTDDFND | SHS NEW | 274.36K | SH | $21.74M 5.00% | 0.00 | 274.36K | 0.00 |
ALUMIS INCDFND | COM | 856.06K | SH | $18.86M 4.33% | 0.00 | 856.06K | 0.00 |
BRIGHT MINDS BIOSCIENCES INCDFND | COM NEW | 220K | SH | $16.05M 3.69% | 0.00 | 220K | 0.00 |
ANNEXON INCDFND | COM | 2.50M | SH | $13.85M 3.18% | 0.00 | 2.50M | 0.00 |
KALVISTA PHARMACEUTICALS INCDFND | COM | 675K | SH | $13.59M 3.12% | 0.00 | 675K | 0.00 |
IMMUNOVANT INCDFND | COM | 545.63K | SH | $13.55M 3.11% | 0.00 | 545.63K | 0.00 |
JADE BIOSCIENCES INCDFND | COM NEW | 964.46K | SH | $13.55M 3.11% | 0.00 | 964.46K | 0.00 |
CONTINEUM THERAPEUTICS INCDFND | CL A | 800.20K | SH | $10.45M 2.40% | 0.00 | 800.20K | 0.00 |
ZENAS BIOPHARMA INCDFND | COM | 524.07K | SH | $10.25M 2.35% | 0.00 | 524.07K | 0.00 |
NEUROGENE INCDFND | COM | 500K | SH | $10.08M 2.32% | 0.00 | 500K | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSDFND | CLASS A ORD | 500K | SH | $9.32M 2.14% | 0.00 | 500K | 0.00 |
CLIMB BIO INCDFND | COM | 1.33M | SH | $9.14M 2.10% | 0.00 | 1.33M | 0.00 |
ORUKA THERAPEUTICS INCDFND | COM | 183.33K | SH | $8.99M 2.07% | 0.00 | 183.33K | 0.00 |
EUPRAXIA PHARMACEUTICALS INCDFND | COM | 1.20M | SH | $8.69M 2.00% | 0.00 | 1.20M | 0.00 |
VERA THERAPEUTICS INCDFND | CL A | 199.35K | SH | $8.02M 1.84% | 0.00 | 199.35K | 0.00 |
EVOMMUNE INCDFND | COM SHS | 325K | SH | $7.47M 1.72% | 0.00 | 325K | 0.00 |
LB PHARMACEUTICALS INCDFND | COM SHS | 300K | SH | $7.40M 1.70% | 0.00 | 300K | 0.00 |
COMPASS THERAPEUTICS INCDFND | COM | 1.35M | SH | $7.14M 1.64% | 0.00 | 1.35M | 0.00 |
SCYNEXIS INCDFND | COM NEW | 7.55M | SH | $6.93M 1.59% | 0.00 | 7.55M | 0.00 |
Page 1 of 2